Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandinavian ChemoTech receives a final injunction from the European Patent Office

Scandinavian ChemoTech AB announces today that the Company has received a final injunction from the European Patent Office where the examiner announces that the patent for the Company's innovation, for TSE treatment of skeletal metastases and deep-seated tumours, will be granted.The patent covers a specially developed electrode as well as unique dynamic properties, which already exist in the TSE platform, intended to treat tumours without damaging important parts of organs and tissues such as nerve pathways and blood vessels. This is of utmost importance in the treatment of, among other

Olvi plc: Notification of Manager’s Transactions

Olvi plc                Stock Exchange Release 3 FEB 2021 AT 4.30 pm Olvi plc: Notification of Manager’s Transactions Person subject to the notification requirementName: Multanen LauriPosition: Other Senior ManagementIssuerName: Olvi plcLEI: 7437003NX7WWVRT6AJ55Initial notificationReference number: 7437003NX7WWVRT6AJ55_20210203122016_3 Transaction detailsTransaction date: 2.2.2021Venue: Outside a trading venueNature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE OF REMUNERATIONInstrument: ShareISIN: FI0009900401Volume: 1 500                Unit price:

Olvi plc: Notification of Manager’s Transactions

Olvi plc                Stock Exchange Release 3 FEB 2021 AT 4.30 pm Olvi plc: Notification of Manager’s Transactions Person subject to the notification requirementName: Heikkilä OlliPosition: Other Senior ManagementIssuerName: Olvi plcLEI: 7437003NX7WWVRT6AJ55Initial notificationReference number: 7437003NX7WWVRT6AJ55_20210203135659_2 Transaction detailsTransaction date: 2.2.2021Venue: Outside a trading venueNature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE OF REMUNERATIONInstrument: ShareISIN: FI0009900401Volume: 1 500                Unit price:

Olvi plc: Notification of Manager’s Transactions

Olvi plc                Stock Exchange Release 3 FEB 2021 AT 4.30 pm Olvi plc: Notification of Manager’s Transactions Person subject to the notification requirementName: Aho LassePosition: Chief Executive OfficerIssuerName: Olvi plcLEI: 7437003NX7WWVRT6AJ55Initial notificationReference number: 7437003NX7WWVRT6AJ55_20210203152000_2 Transaction detailsTransaction date: 2.2.2021Venue: Outside a trading venueNature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE OF REMUNERATIONInstrument: ShareISIN: FI0009900401Volume: 7 200               Unit price: 0.

Hampstead Garden Suburb – Growing the London Network

Adding yet another location to the London network of Brewers stores, now 30 strong, our latest opening in Hampstead Garden Suburb is conveniently positioned on the A1 (Lyttelton Road).  The store also offers free delivery* to the surrounding area including, but not restricted to Highgate, Hampstead Heath, Finchley, Finsbury Park and Brent Cross. With over 10 years of experience in the industry and the local area, our team in the Hampstead store are ready to help decorators and DIYers alike!  You’ll find everything you need for decorating all under one roof at the new store, plus our

Roar BidCo's outstanding public offer for Recipharm AB (publ) – Consent granted to correct error in the Convertible Bond Terms

On 14 December 2020, EQT IX[1] ("EQT IX"), through Roar BidCo AB[2] ("Roar BidCo"), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the "Convertible Bonds") ("Holders of Convertible Bonds") in Recipharm AB (publ) ("Recipharm" or the "Company") to tender all their shares[3] and Convertible Bonds to Roar BidCo (the "Offer"). An offer document relating to the Offer was made public on 17 December 2020 (the "Offer Document"). The Offer was subsequently increased on 28 January 2021 (the "Revised Offer"). A supplement to the Offer Document was

Invitation – Presentation of Sobi’s Q4 and FY 2020 results

On 18 February, at 08:00 CET, Swedish Orphan Biovitrum AB (publ)  (Sobi™) will publish its report for the forth quarter and full-year 2020. Investors, financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, on the same day at 13:00 CET. The event will be hosted by Sobi’s CEO and President, Guido Oelkers, and the presentation will be held in English. The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi’s website

Handheld Continues Expansion and Local Support with New North American Regional Sales Managers

[Lidköping, Sweden, February 3, 2021.] Handheld Group , a leading global manufacturer of rugged mobile computers, continues its ongoing commitment to provide customers with personalized support at a local level with the addition of two new Regional Sales Managers for Handheld US, Rob Bollweg and John Townsend. Both join Handheld after working directly for a Handheld reselling partner, so they share a comprehensive understanding of the needs and requirements of companies who sell Handheld

Selvaag Bolig ASA: Mandatory notification of trades by primary insiders

Gisele Marchand, director, purchased 450 shares on 3. February 2021. The shares were purchased at an average at a price of NOK 54.90. Following this transaction, Marchand owns 5 450 shares in Selvaag Bolig ASA. As previously communicated at the 2020 AGM, shareholder-elected directors have received NOK 50 000 each to purchase shares.   This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Irisity and Axis enter into partnership developing deep learning powered intelligent cameras

Irisity AB (publ), an ADP, Axis Development Partner, has developed an embedded version of IRIS to be integrated into Axis TPU cameras resulting in a unique deep learning capable AI camera.Through the Axis Communications partnership program, Irisity integrates an embedded version of its cutting-edge IRIS algorithms for Axis' next generation Tensor Processing Unit TPU, based cameras. This enables advanced deep learning capabilities fully autonomously on Axis cameras without any need for server or cloud support.  · We are happy to have Irisity in our ADP program and are looking forward to

Webstep ASA: Fourth quarter 2020 results presentation

Oslo, 3 February 2021: Please note that Webstep ASA will announce its fourth quarter 2020 results Wednesday 17 February 2021.The fourth quarter 2020 presentation will be available via the following webcast link at 9:00 am CET the same day: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210216_11 The interim report and the slides from the presentation will be available at https://investor.webstep.com/Investors/reports-and-presentations/ from 7:00 am CET the same day.

Transcom Holding AB (publ): Invitation to Transcom fourth quarter 2020 results presentation

Transcom are pleased to invite you to their Q4 2020 financial update call on Wednesday, February 17, at 9:00 CET, following the release of Q4 2020 results at 8:00 am CET. The press release will include a link to the presentation for the call. The materials will also be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Snejana Koleva, CFO Presentation details Date/Time: Wednesday, February 17, 2021 at 9:00 CET Online Registration link: http://emea.directeventreg.com/registration/3358027 Important note:

Medius positioned as a Leader in IDC MarketScape report

STOCKHOLM, 2 February 2021 Medius, a leading provider of cloud-based spend management solutions, today announces that it has been named a ‘Leader’ in the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Accounts Payable Automation Applications for Midmarket 2020–2021 Vendor Assessment (doc # US47032620, December 2020).The IDC MarketScape report highlights Medius’ ability to automate the entire AP invoice process from receipt to payment, providing their customers with complete control of cash, cost, and compliance. Further, the report notes that, with its cloud-native architecture,

Metso Outotec starts negotiations concerning reorganization of its Sweden operations

Metso Outotec Corporation press release, February 3, 2021 at 14.30 EETMetso Outotec has convened local trade unions to negotiations concerning the restructuring and operational reduction of its operations in Sweden. The measures relate to new product strategy and business model changes and synergy targets from the Metso Outotec merger. The Swedish operations have issued a negotiation proposal, according to which the total reduction need in Sweden is approximately 80 white collar positions mainly in the Minerals, Metals and Services business areas in the Skellefteå and Sala locations.

DM Dental chooses Planmeca for optimal daily workflows

DM Dental in Dongguan, China, opened in 2020 with the goal to employ optimised and efficient digital workflows from the very beginning. With Planmeca solutions, the clinic has been able to streamline both digital workflows as well as daily internal and external infection control routines in order to guarantee safe treatment conditions for the clinic staff and patients from day one – even amidst the Covid-19 pandemic. DM Dental is a dental clinic located in Dongguan, Guangdong province in China. Founded in 2020 by Dr Xianghua Cheng, the clinic offers high-end dental services for

Director/PDMR Shareholding

3 February 2021   Independent Oil and Gas plc   Director/PDMR Shareholding   Independent Oil and Gas plc ("IOG" or the "Company"), (AIM: IOG.L), the UK gas company targeting high returns via an infrastructure-led hub strategy, announces that, on 3 February 2021, Andrew Hockey, CEO of the Company, sold 120,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 16.00 pence per Ordinary Share and then repurchased, into his ISA, the same number of Ordinary Shares in the Company at an average price of 16.35 pence per Ordinary Share to facilitate an

Approval of Glucosparc (metformin)

The pharmaceutical Glucosparc prolonged release tablet 500mg, 750mg and 1000mg, has been approved for sale in Sweden by the Medical Products Agency.Glucosparc is a prescription drug that is used to treat type 2 diabetes in adults where only exercise and diet are not enough to control blood sugar levels. Glucosparc may be used alone or combined with other drugs that lowers blood sugar. Glucosparc contains metformin, a substance that increases the effect of the body's own insulin, which in turn is needed for the body's cells to be able to get energy from glucose, the sugar that is absorbed

Momentum Group acquires Mekano – further strength­ening its position in industrial services in Sweden

Momentum Group has signed an agreement today to acquire 70 percent of the shares in Mekano AB and 100 percent of the shares in Mekano i Sävedalen AB, thereby further strengthening the Group’s market position in service and maintenance for Swedish industry. Mekano is one of Sweden’s leading suppliers of products and services for the industrial services market and will be part of Momentum Group’s business area Components & Services. The two Mekano companies generate combined annual revenue of approximately MSEK 145 with favourable profitability and have about 85 employees. Mekano is a

Year-End Report 1 January – 31 December 2020

”Significant growth ended the year” 1 OCTOBER – 31 DECEMBER 2020 (3 MONTHS) · Net sales increased by 75 percent to SEK 1,731 million (988), of which organic growth amounted to 51 percent and acquired growth amounted to 29 percent. · EBITA increased by 208 percent to SEK 316 million (102), corresponding to an EBITA-margin of 18.2 percent (10.4). · Profit after tax increased by 343 percent to SEK 219 million (49). · Earnings per share amounted to SEK 1.94 (0.44). · Cash flow from operating activities amounted to SEK 559 million (175). · During the quarter, four

Information about the trading in subscription rights and BTA

Stayble Therapeutics AB (”Stayble” or the ”Company”) hereby informs that the first day of trading in subscription rights and paid subscribed share ("BTA"), in connection with the Company's ongoing rights issue, has been rescheduled for tomorrow, Thursday, 4 February 2021 due to an administrative and technical delay. The first day of trading in subscription rights and BTA was previously planned for today, 3 February 2021.Due to an administrative and technical delay, Stayble hereby informs that the subscription rights will be traded on Nasdaq First North Growth Market during the period 4 - 15

Leveraging user generated content to build authenticity

Content makes a differenceWe all know that content makes a difference. On websites, in blog posts, in advertising. We want to create content that inspires, that educates and that converts. Quality content requires an investment. You need time to plan, schedule and publish it. You need to hire a writer. Someone to photograph the products. An agency to design ads. But there is a type of content out there that many are taking for granted. Content that is essentially free to use and that doesn’t require copywriters, professional photography nor agencies. Most importantly, it is proven

Financial Report October - December 2020

Financial Summary - Q4'20 · Financial performance better than expectations · Net Sales $455 million, Organic Sales[1] increase 17% · Active Safety Net Sales increase 38%, Organic Sales increase 31% · Operating cash flow $(77) million, $27 million improvement YoY · Cash balance $758 million Outlook - FY'21 · Organic Sales[1]  growth YoY is expected to exceed 25% · Active Safety Organic Sales[1] growth YoY is expected to be ~45% · Currency translation impact is expected to be ~5% · Operating loss is expected to improve in 2021 from 2020, Cash balance is

Vestas wins 75 MW order in Ireland

News release from Vestas Northern and Central EuropeHamburg, 3 February 2021 Vestas has secured an order for the 75 MW Cloncreen project in Ireland from the Irish climate solutions company Bord na Móna. The contract includes supply, installation and commissioning of 21 V136-3.45 MW wind turbines in 3.6 MW operating mode in combination with a 20-year Active Output Management 5000 (AOM 5000) service agreement, maximising power production while at the same time offering competitive levelised cost of energy. This project is located in County Offaly in the Irish Midlands and it is

Results of meeting of the holders of Recipharm convertible bonds: consent granted to correct error in terms and conditions

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (“MAR”).FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER THAN “U.S. PERSONS” (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT “)). NOT FOR RELEASE, PUBLICATION OR DISTIRBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

There are no items matching the current filter
There are no more items matching the current filter
Back to top